26
|
Walraven I, Kwint M, Marshall S, Verheij M, Belderbos J, Janssen T. P2.14-020 Clinical Validation of NTCP-Models for Esophagus Toxicity in Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiation. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
27
|
Janssen T, Dikstaal A, Kwint M, Marshall S, Wolf A, Knegjens J, Moonen L, Belderbos J, Sonke J, Verheij M, Van Vliet-Vroegindeweij C. OC-0040: Validation of prospective electronic toxicity registration to audit dose constraints. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30484-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
28
|
Lambrecht M, Sonke J, Verheij M, Hurkmans C. OC-0539: A multicentre QA study on 4DCT and IMRT/VMAT techniques for lung SBRT using a respiratory phantom. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30979-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
Essers P, Verhagen C, Van der Heijden M, Van den Brekel M, Bartelink H, Verheij M, Vens C. OC-0463: In vitro prediction of DNA repair defects reveals association with poor clinical outcome in HNSCC. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30904-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
30
|
Lambrecht M, Ortega Marin K, La Fontaine M, Sonke J, Boellaard R, Verheij M, Hurkmans C. EP-1682: Comparison of SUV based on different ROIs and VOIs definitions: a multi-center 4D phantom study. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32214-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
31
|
Van Pelt V, Kruis M, Van de Lindt T, Ter Beek L, Verheij M, Van der Heide U. PO-0904: Development of an MRI-protocol for radiotherapy treatment guidance in gastric cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31341-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
32
|
Claassen Y, De Steur W, Hartgrink H, Van Sandick J, Dikken J, Meershoek-Klein Kranenberg E, Braak J, Jansen E, Van Grieken N, Putter H, Trip A, Boot H, Cats A, Sikorska K, Van Tinteren H, Verheij M, Van de Velde C. Surgicopathological quality control in the CRITICS gastric cancer trial. Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30104-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
33
|
Verkooijen H, Kerkmeijer L, Fuller D, Huddart R, Faivre-Finn C, Verheij M, Sahgal A, Hall E, van Vulpen M. Evaluation of innovation in radiation oncology: R-IDEAL. Int J Surg 2016. [DOI: 10.1016/j.ijsu.2016.11.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
34
|
Vogel WV, Lam MGEH, Pameijer FA, van der Heide UA, van de Kamer JB, Philippens ME, van Vulpen M, Verheij M. Functional Imaging in Radiotherapy in the Netherlands: Availability and Impact on Clinical Practice. Clin Oncol (R Coll Radiol) 2016; 28:e206-e215. [PMID: 27692741 DOI: 10.1016/j.clon.2016.09.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2016] [Revised: 07/10/2016] [Accepted: 07/11/2016] [Indexed: 12/25/2022]
Abstract
AIMS Functional imaging with positron emission tomography/computed tomography (PET/CT) and multiparametric magnetic resonance (mpMR) is increasingly applied for radiotherapy purposes. However, evidence and experience are still limited, and this may lead to clinically relevant differences in accessibility, interpretation and decision making. We investigated the current patterns of care in functional imaging for radiotherapy in the Netherlands in a care evaluation study. MATERIALS AND METHODS The availability of functional imaging in radiotherapy centres in the Netherlands was evaluated; features available in >80% of academic and >80% of non-academic centres were considered standard of care. The impact of functional imaging on clinical decision making was evaluated using case questionnaires on lung, head/neck, breast and prostate cancer, with multiple-choice questions on primary tumour delineation, nodal involvement, distant metastasis and incidental findings. Radiation oncologists were allowed to discuss cases in a multidisciplinary approach. Ordinal answers were evaluated by median and interquartile range (IQR) to identify the extent and variability of clinical impact; additional patterns were evaluated descriptively. RESULTS Information was collected from 18 radiotherapy centres in the Netherlands (all except two). PET/CT was available for radiotherapy purposes to 94% of centres; 67% in the treatment position and 61% with integrated planning CT. mpMR was available to all centres; 61% in the treatment position. Technologists collaborated between departments to acquire PET/CT or mpMR for radiotherapy in 89%. All sites could carry out image registration for target definition. Functional imaging generally showed a high clinical impact (average median 4.3, scale 1-6) and good observer agreement (average IQR 1.1, scale 0-6). However, several issues resulted in ignoring functional imaging (e.g. positional discrepancies, central necrosis) or poor observer agreement (atelectasis, diagnostic discrepancies, conformation strategies). CONCLUSIONS Access to functional imaging with PET/CT and mpMR for radiotherapy purposes, with collaborating technologists and multimodal delineation, can be considered standard of care in the Netherlands. For several specific clinical situations, the interpretation of images may benefit from further standardisation.
Collapse
|
35
|
Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27:v38-v49. [PMID: 27664260 DOI: 10.1093/annonc/mdw350] [Citation(s) in RCA: 1044] [Impact Index Per Article: 130.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
|
36
|
den Dulk M, Verheij M, Cats A, Jansen EPM, Hartgrink HH, Van de Velde CJH. The Essentials of Locoregional Control in the Treatment of Gastric Cancer. Scand J Surg 2016; 95:236-42. [PMID: 17249271 DOI: 10.1177/145749690609500405] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Gastric cancer is the fourth most frequent cancer in the world. For curative treatment and local control of gastric cancer, surgery is essential. The extent of the lymph node dissection is still under debate. Only one available trial showed significantly increased overall survival, whereas in all other randomised trials no significant difference could be found. As surgery alone often is not sufficient in the curative treatment in gastric cancer, different (neo)adjuvant treatment strategies have extensively been studied. The recently published MAGIC trial showed downstaging, downsizing and an improved overall survival for patients treated with perioperative chemotherapy, compared to surgery alone (difference 13%, p = 0.009). The INT 0116 trial on the other hand, demonstrated the benefit of postoperative chemoradiotherapy compared to surgery alone for patients with a curative resection of gastric cancer. However, the quality of resections in this trial was poor, illustrating the importance of standardisation by quality control. This could be done by the Maruyama index, which quantifies the likelihood of unresected disease. In the Netherlands, the CRITICS trial has recently been launched, which will be a quality controlled trial comparing postoperative chemoradiotherapy and chemotherapy on survival and/or locoregional control in patients who receive neoadjuvant chemotherapy followed by a D1+ gastric resection.
Collapse
|
37
|
Verheij M, Cats A, Jansen Edwin P, van Grieken Nicole C, Aaronson Neil K, Boot H, Lind Pehr A, Meershoek – Klein Kranenbarg E, Nordsmark M, Putter H, van Tinteren H, Van De Velde Cornelis J. LBA-02 A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: first results from the CRITICS study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw237.02] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
De Jong M, Van den Brekel M, Verheij M. SP-0567: The new 'R's; in radiation biology. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31817-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
39
|
Verheij M, Slotman BJ. [Radiotherapy in Europe]. NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE 2016; 160:D207. [PMID: 27334085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Radiotherapy plays an important part in the curing of cancer patients and is an effective treatment for tumour-related symptoms. However, in many countries the level of access to this treatment modality is unacceptably low due to shortage of infrastructure, modern apparatus and trained staff. In Europe it is mainly the Eastern European countries that are behind in the provision of and accessibility to radiotherapy. Worldwide investment to narrow the gap would put an end to these undesirable differences. In addition, these investments would deliver economic benefits, especially in low-to-middle income countries. In this article, on the basis of a number of recently published reports, we discuss the differences that exist in the geographical spread of radiotherapy departments and the availability of apparatus within Europe. In conclusion we also take a short look at the Dutch situation.
Collapse
|
40
|
Haan RD, Pluim D, Van Triest B, Verheij M, Schellens J, Vens C. 351 Sensitive pharmacodynamic assessment of PARP inhibitors for individualized treatment in clinic. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30214-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Zerp S, Stoter T, Hoebers F, Van den Brekel M, Dubbelman R, Kuipers G, Lafleur V, Slotman B, Verheij M. PO-1060: Combining radiation with the pan-Bcl-2 inhibitor AT-101: in vitro studies and clinical pharmacokinetics in HNSCC. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41052-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
42
|
Hamming-Vrieze O, Depauw N, Craft D, Chan A, Verheij M, Sonke J, Kooy H. PO-0791: Interpretation of uncertainty scenarios for head and neck IMPT treatment plans using TCP and NTCP models. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40783-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
43
|
Trip A, Sikorska K, Boot H, Cats A, Van Sandick J, Jansen E, Verheij M. PO-0694: Radiation dose-dependent changes of the spleen following chemoradiotherapy for gastric cancer. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40686-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
44
|
Dayal S, Verheij M, Chalmers A. EP-1160 Increasing radiotherapy responsiveness of mesothelioma by activating tumour specific cell death. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41152-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
45
|
Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 24 Suppl 6:vi57-63. [PMID: 24078663 DOI: 10.1093/annonc/mdt344] [Citation(s) in RCA: 227] [Impact Index Per Article: 22.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|
46
|
Rottenberg S, Borst G, Gasparini A, Barazas M, Guyader C, Sol W, Kersbergen A, Verheij M, Sonke J. 169: Homologous recombination deficiency and radio-curability in mouse models for BRCA1/2-deficient breast cancer. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)34190-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
47
|
Verheij M. 208: The ART of translation. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)34229-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
48
|
Verheij M. SP-0370: Radiotherapy. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30475-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
49
|
Van Berlo D, Gasparini A, Verheij M, Sonke J, Vens C. OC-0051: Towards the clinic: application of μ-IGRT for assessment of radiationinduced pneumonitis and pulmonary fibrosis. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30156-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
50
|
Borst G, Coackley C, Yucel H, Guyader C, Berlin A, Sonke J, Verheij M, Jonkers J, Rottenberg S, Bristow R. OC-0487: Genetically engineered breast cancer mouse models to explore and target radioresistance. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30592-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|